Navigation Links
Lpath Demonstrates 'First-in-Class' AMD Results With Its Lead Drug,Candidate, Sphingomab

d uncertainties, many of which are beyond our control and may cause actual results to differ materially from stated expectations. For example, there can be no assurance that required clinical trials will be successful, necessary regulatory approvals will be obtained, or the proposed treatments will prove to be safe or effective. Actual results may also differ substantially from those described in or contemplated by this press release due to risks and uncertainties that exist in our operations and business environment, including, without limitation, our limited experience in the development of therapeutic drugs, our dependence upon proprietary technology, our history of operating losses and accumulated deficits, our reliance on research grants, current and future competition, and other risks described from time to time in our filings with the Securities and Exchange Commission. We undertake no obligation to release publicly the results of any revisions to these forward-looking statements to reflect events or circumstances arising after the date hereof.

    Contact:


    Scott Pancoast                      Investor Relations

    (858) 678-0800 x104                 Liolios Group, Inc.

                     Scott Liolios or Ron Both

    www.lpath.com                       (949) 574-3860

spancoast@lpath.com

CONTACT: Scott Pancoast of Lpath, Inc., +1-858-678-0800, ext. 104,; or Investor Relations, Scott Liolios or Ron Both, bothof Liolios Group, Inc., +1-949-574-3860, for Lpath, Inc. spancoast@lpath.com

Web site: http://www.lpath.com/

Ticker Symbol: (NASDAQ-OTCBB:LPTN)

Terms and conditions of use apply
Copyright © 2007 PR Newswire Association LLC. All rights reserved.
A United
'"/>




Page: 1 2 3 4

Related medicine technology :

1. The International Myeloma Foundation Says Data Reported at a Global Medical Meeting in Greece Demonstrates Improved Survival for a Wide Range of Myeloma Patients
2. Publication on Pixantrone Preclinical Studies Demonstrates Reduced Cardiotoxicity Compared to Equiactive Doses of Doxorubicin and Mitoxantrone
3. New Research Demonstrates Broad Efficacy of Azixa (MPC-6827) Against Multiple Tumor Types and in Drug Resistant Cell Lines
4. Algeta Demonstrates Targeted Cancer-killing Potential of Novel Alpha Particle Linked Antibodies in Leading Medical Journal Blood
5. Gerons Telomerase Inhibitor Cancer Drug Demonstrates Good Pharmacokinetics and Tolerability in Phase I/II Trial
6. Frova Phase III Study Data Demonstrates That Short-Term Prevention Treatment Reduces Frequency and Severity of Menstrual Migraine
7. Mymetics HIV Vaccine Demonstrates First-Ever Production of Neutralizing IgA Antibodies in Non-Human Primate Model
8. Newly Published Data Demonstrates Superiority of Cipralex Over Duloxetine for Acute Treatment of Depression
9. Introgens Advexin Demonstrates Clinical Benefit in Inherited Cancer
10. Prostate Cancer: Clinical Study Demonstrates Superior Efficacy of Docetaxel Chemotherapy
11. Taxus VI Clinical Trial Demonstrates Positive Long-Term Outcomes for Moderate-Release Paclitaxel-Eluting Stent at Four Years
Post Your Comments:
(Date:7/13/2014)... , July 13, 2014  Eli Lilly ... announced results from its non-clinical study in genetically ... version of the beta-amyloid antibody N3pG and beta-secretase ... therapy was more effective in removing clumps of ... that is thought to lead to Alzheimer,s disease ...
(Date:7/11/2014)... 11, 2014 Patient engagement has become ... organizations are turning to an assortment of marketing ... part of this evolving approach to patient engagement, ... and engage patients throughout their experiences with a ... By mapping the patient journey and employing a ...
(Date:7/11/2014)... 2014  Rock Creek Pharmaceuticals, Inc. (NASDAQ: ... the Food and Drug Administration ("FDA"), has notified the ... Investigational New Drug ("IND") application before granting the Company ... Dr. Chris Chapman , RCP,s President, ... our IND. When we receive the agency,s official comments ...
Breaking Medicine Technology:New Data Shows Combination Therapy is More Effective than Monotherapy in Removing Beta-Amyloid Plaques from the Brains of Mice 2New Data Shows Combination Therapy is More Effective than Monotherapy in Removing Beta-Amyloid Plaques from the Brains of Mice 3New Study Uses Six-Step Patient Journey as Framework for Consumer-Focused Marketing Opportunities 2Rock Creek Pharmaceuticals Issues Update On US Investigational New Drug Application 2
... , , , ... dog owners in the Midwest will find that getting their pets, hearts ... Dog Heart Health Tour will make stops with a sound-proof medical unit ... on August 30 to perform free dog heart examinations. , , ...
... MIAMI, Aug. 17 Stereotactic body radiotherapy (SBRT) is ... metastases, reported in new research from The University of Texas in ... CyberKnife Centers of Miami and Palm Beach. , ( www.cyberkni ... , "This data confirms the established method of ...
Cached Medicine Technology:Midwest Mobile Dog Heart Health Tour to Provide Free Heart Examinations 2Midwest Mobile Dog Heart Health Tour to Provide Free Heart Examinations 3New Research Shows Effectiveness of Stereotactic Body Radiotherapy for Spinal Tumors 2
(Date:7/13/2014)... 2014 The North American water storage systems ... to $5,450 million by 2018, at a CAGR of 21.0%, ... expanding at a rapid pace in North America. The U.S. ... on water & wastewater storage and collection, and the increased ... is expanding at a healthy rate in Canada, and is ...
(Date:7/13/2014)... July 13, 2014 The report ... Molybdenum, Iron), Form (Chelated & Non Chelated), Application ... - Global Trends and Forecast to 2018” defines ... an analysis and forecasting of the global value ... the driving and restraining factors for the global ...
(Date:7/13/2014)... 13, 2014 Fuel additives are chemicals, ... diesel, jet fuel, kerosene, and so on, in order ... for reducing the corrosion effects caused by fuels and ... to any fuel, provide economies of scale in the ... the overall cost of the fuel products. , The ...
(Date:7/13/2014)... 13, 2014 MarketsandMarkets recently conducted ... Modeling; 3D Scanning; 3D rendering; Layout and Animation; ... (2013 - 2018)”, which analyzes and studies the ... America, Western Europe, Eastern Europe, Middle East and ... draws the competitive landscape of the 3D imaging ...
(Date:7/13/2014)... Serena Gordon HealthDay Reporter ... new type of sensor for people with diabetes is being ... instead of blood, researchers report. Scientists at Brown University ... using artificial saliva. It uses light, metal and a special ... "Everybody knows that diabetics have to prick their fingers to ...
Breaking Medicine News(10 mins):Health News:North American Water Storage Systems Market is Expected to Reach $5,450 million by 2018 - New Report by MicroMarket Monitor 2Health News:North American Water Storage Systems Market is Expected to Reach $5,450 million by 2018 - New Report by MicroMarket Monitor 3Health News:Micronutrient Market Worth $6,474.6 Million by 2018 - A Report by MarketsandMarkets 2Health News:Micronutrient Market Worth $6,474.6 Million by 2018 - A Report by MarketsandMarkets 3Health News:Micronutrient Market Worth $6,474.6 Million by 2018 - A Report by MarketsandMarkets 4Health News:North America Fuel Additives Market is Expected to Reach $8,100 Million by 2017 - New Report by MicroMarket Monitor 2Health News:North America Fuel Additives Market is Expected to Reach $8,100 Million by 2017 - New Report by MicroMarket Monitor 3Health News:North America Fuel Additives Market is Expected to Reach $8,100 Million by 2017 - New Report by MicroMarket Monitor 4Health News:3D Imaging Market Worth $9.82 Billion By 2018 - Report by MarketsandMarkets 2Health News:3D Imaging Market Worth $9.82 Billion By 2018 - Report by MarketsandMarkets 3Health News:3D Imaging Market Worth $9.82 Billion By 2018 - Report by MarketsandMarkets 4Health News:Saliva Test Might Someday Replace Needle Prick for Diabetics 2Health News:Saliva Test Might Someday Replace Needle Prick for Diabetics 3
... and supports the first module, targeting ... ... Today at the,Healthcare Information and Management Systems Society (HIMSS) 2008 Annual,Conference ... Tool (PSST), a software-based solution designed to,help healthcare organizations identify potential ...
... cell differentiation into different kinds of tissues in embryos, plays ... life, said researchers from Baylor College of Medicine in Houston ... Nature Medicine. Their findings may provide a basis for understanding ... bone. , We knew that Notch is important in patterning ...
... ... Advances Made in Understanding Biology of Addiction ,and That is Finally ... ... Although the American Medical,Association recognized addiction as a disease back in 1956, ...
... the Lesbian, Gay, Bisexual and Transgender ... Movement By Early Microsoft Employee Pride Foundation ... Pride Foundation of Seattle is honored,to announce the establishment of ... Weiland,s gift of $65 million is the largest single bequest,ever ...
... to Forfeit Certain Shares; Oracle to Reschedule ... Special Meeting for March 5, 2008, GREENWICH, ... OHAQW and OHAQU) ("Oracle"),announced today that it has reached an agreement ... and,Plan of Merger, dated as of December 3, 2007 and previously ...
... finds tobacco users diagnosed almost 7 years earlier than ... and people with significant exposure to secondhand smoke should ... years earlier than the current recommended age of 50, ... of Rochester Medical Center in New York analyzed the ...
Cached Medicine News:Health News:Microsoft Introduces Patient Safety Screening Tool to Stop Spread of In-Hospital Infections 2Health News:Microsoft Introduces Patient Safety Screening Tool to Stop Spread of In-Hospital Infections 3Health News:Microsoft Introduces Patient Safety Screening Tool to Stop Spread of In-Hospital Infections 4Health News:Notch controls bone formation and strength 2Health News:NEWSWEEK Cover: The Hunt for an Addiction Vaccine 2Health News:NEWSWEEK Cover: The Hunt for an Addiction Vaccine 3Health News:NEWSWEEK Cover: The Hunt for an Addiction Vaccine 4Health News:Ric Weiland Leaves $65 Million to Support Gay Rights and HIV/AIDS Organizations 2Health News:Ric Weiland Leaves $65 Million to Support Gay Rights and HIV/AIDS Organizations 3Health News:Oracle Healthcare Acquisition Corp. and Precision Therapeutics, Inc. Agree in Principle to Amend Merger Agreement to Reduce Consideration by 15% 2Health News:Oracle Healthcare Acquisition Corp. and Precision Therapeutics, Inc. Agree in Principle to Amend Merger Agreement to Reduce Consideration by 15% 3Health News:Oracle Healthcare Acquisition Corp. and Precision Therapeutics, Inc. Agree in Principle to Amend Merger Agreement to Reduce Consideration by 15% 4Health News:Oracle Healthcare Acquisition Corp. and Precision Therapeutics, Inc. Agree in Principle to Amend Merger Agreement to Reduce Consideration by 15% 5Health News:Earlier Colon Cancer Screens Urged for Smokers 2
Colloidal Gold Conjugated, Goat anti-human IgM (Mu Chain) - 50 OD...
Colloidal Gold Conjugated, Goat anti-human IgA (Alpha Chain) - 50 OD...
Polyester ribbon impregnated with conjugated Protein A - .50 OD per sq. cm....
Polyester ribbons (3) impregnated with different OD values of conjugated Protein G...
Medicine Products: